Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates.
Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates. Aliment Pharmacol Ther. 2007 Nov 01; 26(9):1179-86.